Glibenclamide/metformin: Difference between revisions
Content deleted Content added
m added index |
m cleanup |
||
| Line 29: | Line 29: | ||
<!-- Identifiers --> |
<!-- Identifiers --> |
||
| |
| CAS_number = 338752-31-1 |
||
| index2_label = metformin hydrochloride |
| index2_label = glyburide/metformin hydrochloride |
||
| CAS_number_Ref = {{cascite|correct|CAS}} |
|||
| CAS_number = 10238-21-8 |
|||
| CAS_number2_Ref = {{cascite|correct|CAS}} |
| CAS_number2_Ref = {{cascite|correct|CAS}} |
||
| CAS_number2 = 1115-70-4 |
| CAS_number2 = 10238-21-8/1115-70-4 |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = SX6K58TVWC |
|||
| UNII2_Ref = {{fdacite|correct|FDA}} |
| UNII2_Ref = {{fdacite|correct|FDA}} |
||
| UNII2 = 786Z46389E |
| UNII2 = SX6K58TVWC/786Z46389E |
||
| ATCvet = |
| ATCvet = |
||
| ATC_prefix = None |
| ATC_prefix = None |
||
Revision as of 17:12, 26 February 2021
| Combination of | |
|---|---|
| Glyburide (Glibenclamide) | Sulfonylurea |
| Metformin | Biguanide |
| Clinical data | |
| Trade names | Glucovance |
| Other names | glyburide/metformin |
| AHFS/Drugs.com | Professional Drug Facts |
| MedlinePlus | a699055 |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
|
| UNII |
|
| KEGG | |
Glibenclamide/metformin, also known as glyburide/metformin and sold under the brand name Glucovance, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes. It contains glibenclamide, a sulfonylureas, and metformin, a biguanide.[1]
References
- ^ "Glyburide and metformin hydrochloride tablet". DailyMed. 10 June 2020. Retrieved 11 August 2020.
External links
- "Glyburide mixture with Metformin hydrochloride". Drug Information Portal. U.S. National Library of Medicine.
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
